Cardiopatie e rischio cardiovascolare in pazienti candidati alla terapia antitumorale. Che cosa deve sapere l'oncologo

Cardiac function should be monitored using echocardiography before and during therapy, guiding oncologist's choice of therapy; oncologists must be aware of cardiovascular risk in order to avoid or prevent adverse cardiovascular effects of the chemotherapy. The cardio-oncology is representative of the optimal cooperation between cardiologists and oncologists.